Treatment Opportunities in Graves' disease.
| dc.contributor.advisor | Bodor, Miklós | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Belgyógyászati Intézet | hu_HU |
| dc.contributor.author | Madu, Tochukwu Job | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Harangi, Mariann | |
| dc.contributor.opponent | Juhász, Éva | |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Belgyógyászati Intézet | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Gyermekgyógyászati Intézet | hu_HU |
| dc.date.accessioned | 2021-06-16T11:07:04Z | |
| dc.date.available | 2021-06-16T11:07:04Z | |
| dc.date.created | 2020-07-28 | |
| dc.description.abstract | I described the treatment Opportunities in Graves' disease. I also described indications and contraindications for each treatment modality. More so, I briefly explored the use of Rituximab which is a novel therapy for Graves' disease treatment. Treatment with Rituximab seems to be promising in the future management of Graves' disease. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 42 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/311158 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Graves' Disease | hu_HU |
| dc.subject | Radioiodine therapy | hu_HU |
| dc.subject | Thyroidectomy | hu_HU |
| dc.subject.dspace | Internal Medicine | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | Treatment Opportunities in Graves' disease. | hu_HU |